We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$3.01B
AUM Growth
-$95.8M
Cap. Flow
-$186M
Cap. Flow %
-6.17%
Top 10 Hldgs %
20.69%
Holding
309
New
19
Increased
61
Reduced
173
Closed
36

Sector Composition

Rank Sector Weight
1 Healthcare 22.55%
2 Industrials 20.61%
3 Technology 18.89%
4 Consumer Discretionary 10.17%
5 Communication Services 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCFS icon
76
FirstCash
FCFS
$8.79B
$14.8M 0.49%
148,124
+46,827
+46% +$4.45M
GDOT icon
77
Green Dot
GDOT
$759M
$14.6M 0.48%
+297,649
New +$16.2M
AGM icon
78
Federal Agricultural Mortgage
AGM
$2.57B
$14.5M 0.48%
199,965
+636
+0.3% +$46.8K
ENSG icon
79
The Ensign Group
ENSG
$10.6B
$14.5M 0.48%
272,400
-93,552
-26% -$4.67M
RDWR icon
80
Radware
RDWR
$1.2B
$14.4M 0.48%
582,557
+83,551
+17% +$2.09M
NUVA
81
DELISTED
NuVasive, Inc.
NUVA
$14.4M 0.48%
245,519
+24,340
+11% +$1.44M
PTC icon
82
PTC
PTC
$16.2B
$14.3M 0.47%
159,156
-11,953
-7% -$1.07M
ICFI icon
83
ICF International
ICFI
$1.67B
$14.2M 0.47%
195,399
+67,116
+52% +$5.03M
CHX
84
DELISTED
ChampionX
CHX
$14.1M 0.47%
421,836
-28,997
-6% -$1.05M
AIMT
85
DELISTED
Aimmune Therapeutics
AIMT
$13.9M 0.46%
669,560
+158,851
+31% +$3.27M
SIX
86
DELISTED
Six Flags Entertainment Corp.
SIX
$13.9M 0.46%
279,422
-32,549
-10% -$1.68M
PGNX
87
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$13.8M 0.46%
2,242,503
-50,676
-2% -$244K
IMMU
88
DELISTED
Immunomedics Inc
IMMU
$13.8M 0.46%
993,297
+347,781
+54% +$5.23M
TDC icon
89
Teradata
TDC
$2.52B
$13.4M 0.45%
373,980
-34,405
-8% -$1.34M
LOPE icon
90
Grand Canyon Education
LOPE
$3.95B
$12.3M 0.41%
105,464
-5,540
-5% -$661K
LKQ icon
91
LKQ Corp
LKQ
$6.2B
$12.3M 0.41%
463,214
-71,971
-13% -$2.01M
MGPI icon
92
MGP Ingredients
MGPI
$369M
$12.2M 0.4%
183,664
+8,283
+5% +$583K
LNN icon
93
Lindsay Corp
LNN
$1.18B
$12M 0.4%
145,883
-11,853
-8% -$992K
INSM icon
94
Insmed
INSM
$28.1B
$12M 0.4%
467,541
-19,571
-4% -$545K
IAA
95
DELISTED
IAA, Inc. Common Stock
IAA
$12M 0.4%
+308,523
New +$12M
BANR icon
96
Banner Corp
BANR
$2.4B
$11.9M 0.4%
219,860
-18,268
-8% -$979K
RVNC
97
DELISTED
Revance Therapeutics, Inc.
RVNC
$11.4M 0.38%
882,769
+765,701
+654% +$9.65M
FC icon
98
Franklin Covey
FC
$240M
$11.4M 0.38%
335,711
+2,691
+0.8% +$79.8K
AIN icon
99
Albany International
AIN
$1.74B
$11.1M 0.37%
134,195
-11,278
-8% -$844K
MCFT icon
100
MasterCraft Boat Holdings
MCFT
$602M
$10.6M 0.35%
541,076
-23,732
-4% -$541K

Similar funds

Rice Hall James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Rice Hall James & Associates held 309 positions worth $3.01B, down 3.1% from $3.11B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates withdrew a net $186M in Q2 2019, closing 36 positions and reducing 173 holdings. Its most notable exit was Globus Medical, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Rice Hall James & Associates opened a new position in Armstrong World Industries worth $26.7M.

  • Rice Hall James & Associates's largest Q2 2019 buy was Armstrong World Industries: 274,237 shares worth $26.7M.
  • Rice Hall James & Associates added most to PGT, Inc. in Q2 2019, an estimated $13M increase.
  • Rice Hall James & Associates's biggest Q2 2019 reduction was Tetra Tech, cutting an estimated $34.1M.
  • Rice Hall James & Associates fully exited Globus Medical in Q2 2019, selling an estimated $15.4M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $3.01B portfolio in Q2 2019.
  • Rice Hall James & Associates opened 19 new positions and closed 36 in Q2 2019.
  • Rice Hall James & Associates's portfolio value fell 3.1% quarter-over-quarter to $3.01B.

Based on Rice Hall James & Associates's 13F filing for Q2 2019, filed 1 Aug 2019.